| |
| |
|
| Insider
Information: |
Berkman Charles S |
| Relationship: |
Chief Legal Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
316,442 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,311,271 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
316,442 |
|
|
| Total
Value |
$3,311,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -14.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Former Executive Officer |
2022-11-01 |
23,825 |
|
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Chief Legal Officer |
2024-04-08 |
292,617 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Asso. Gen. Counsel, SecretaryO |
• – – |
2007-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,263 |
|
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2022-11-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
366,511 |
305,412 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2023-02-15 |
4 |
D |
$3.80 |
$36,263 |
D/D |
(9,543) |
373,939 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2023-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
40,625 |
414,564 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2023-12-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,622 |
267,359 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2023-12-07 |
4 |
D |
$4.85 |
$26,205 |
D/D |
(5,403) |
261,956 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2024-01-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,556 |
279,512 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2024-01-02 |
4 |
D |
$6.25 |
$44,969 |
D/D |
(7,195) |
272,317 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2024-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,322 |
288,064 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2024-02-15 |
4 |
D |
$5.54 |
$42,154 |
D/D |
(7,609) |
286,030 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2024-04-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,541 |
299,571 |
0 |
- |
|
| OABI |
OmniAb, Inc |
Chief Legal Officer |
• – – |
2024-04-08 |
4 |
S |
$5.27 |
$36,648 |
D/D |
(6,954) |
292,617 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Former Executive Officer |
– – – |
2022-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,944) |
23,825 |
0 |
- |
|
| OABI |
OmniAb, Inc |
See Remarks |
• – – |
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
353,716 |
353,716 |
0 |
- |
|
| OABI |
OmniAb, Inc |
See Remarks |
• – – |
2022-12-01 |
4 |
D |
$3.35 |
$35,443 |
D/D |
(10,580) |
343,136 |
0 |
- |
|
| OABI |
OmniAb, Inc |
See Remarks |
• – – |
2022-12-28 |
4 |
D |
$3.66 |
$23,856 |
D/D |
(6,518) |
336,618 |
0 |
- |
|
| OABI |
OmniAb, Inc |
See Remarks |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
46,864 |
383,482 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-02-15 |
4 |
D |
$157.18 |
$162,838 |
D/D |
(1,036) |
25,059 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,780 |
26,839 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,136 |
27,975 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-03-06 |
4 |
D |
$165.87 |
$65,021 |
D/D |
(392) |
27,583 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-06-29 |
4 |
A |
$117.84 |
$21,210 |
D/D |
180 |
27,763 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-09-04 |
4 |
AS |
$254.99 |
$4,951,065 |
D/D |
(19,417) |
27,763 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-09-04 |
4 |
OE |
$21.92 |
$1,358,796 |
D/D |
19,417 |
47,180 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
SVP, Gen. Counsel & Secretary |
• – – |
2018-09-17 |
4 |
AS |
$250.69 |
$705,181 |
D/D |
(2,813) |
27,763 |
0 |
- |
|
94 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
